Integrated Core Strategies (US) LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 4:13 pm Purchase | 2025-12-31 | 13G | BIOXCEL THERAPEUTICS INC N BTAI | Integrated Core Strategies (US) LLC | 1,835,192 8.400% | 807,139 (+78.51%) | Filing |
| 2025-10-01 4:15 pm Purchase | 2025-09-29 | 13G | BIOXCEL THERAPEUTICS INC N BTAI | Integrated Core Strategies (US) LLC | 1,028,053 5.200% | 1,028,053 (New Position) | Filing |